-
FDA approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) caused by susceptible gram-positive organisms including Staphylococcus aureus (MRSA and MSSA), Streptococcus agalactiae, Streptococcus anginosus group, Streptococcus pyogenes, and Enterococcus faecalis.
-
A 46-year-old man was admitted to our hospital due to progressive dyspnea, non-productive cough and fever. Two months prior to admission, he started to develop sustained weight loss and dyspnea associated with exertion. Ten-days prior to his presentation, dyspnea progressed to minimal exertion significantly limiting his functional status.
-
-
At the 51st meeting of the American Society of Tropical Medicine and Hygiene in Denver, November 10-14, 2002, a full symposium was devoted to yellow fever.
-
Conference coverage: emerging infections and outbreaks, malaria, schistosomiasis, bacterial infections
-
The emergence of chronic wasting disease, a transmissible spongiform encephalopathy in North American cervids, raises concern about potential transmission to humans, as has occurred elsewhere with bovine spongiform encephalopathy and vCJD.
-
FDA Approves Generic Version of AstraZenecas Prilosec; Pegasys
Approved To Treat Hepatitis C; HRT Reduces Alzheimers Risk, Study
Says; Heparin Plus Alteplase More Effective; Digoxin Effects Differ By
Sex; McClellan Named FDA Commissioner; FDA Actions
-
An excellent update on rabies was provided by Charles E. Rupprecht, the Rabies Section Chief of the CDC, during the Symposium, Control of Zoonoses: A Veterinary Perspective at the recent 51st annual ASTMH meeting in Denver, Colo.
-
New data and consensus discussions provide updated guidance about the use of hepatitis A vaccine for young children, in US residents, and in individuals who are traveling very soon after their pretravel consultations.
-
Adjunctive therapy with dexamethosone, initiated immediately before or with the first dose of antibiotic, significantly improved outcomes in adults with pneumococcal meningitis.
